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homeotic  developmental  pheno-
types  or  overall  disruption  of  PcG 
body formation.
The Grimaud  et  al.  (2006)  study 
raises  a  number  of  mechanistic 
questions  regarding how  the RNAi 
machinery promotes chromosomal 
pairing  of  PRE-containing  loci. 
First,  it  remains  an  open  question 
as  to  how  PcG  complexes  asso-
ciate  to  form  nuclear  bodies.  As 
there  is  limited  sequence  homol-
ogy among PRE elements, it seems 
likely  that  protein-protein  inter-
actions  between  PcG  proteins  or 
associated  factors mediate  forma-
tion of these complexes. A second 
question  is  whether  PcG  bodies 
are  static  or  dynamic  structures. 
Because  PcG  proteins  dissoci-
ate  from chromatin during mitosis, 
these  contacts  would  have  to  be 
reestablished each cell cycle. Pair-
ing  of  two  endogenous  PRE-con-
taining  loci  to  the  same PcG body 
was  found  to  occur  in  approxi-
mately  one-fourth  of  cells  exam-
ined, suggesting that any given PRE 
could associate with different PREs 
situated  throughout  the  genome. 
Grimaud  et  al.  (2006)  propose 
that,  once  long-distance  contact 




stimulate  transcription  of  dsRNA 
and  siRNA  production  (Figure  1). 
These  RNAs  are  postulated  to  act 
as  a molecular  glue  that  stabilizes 
interactions  between  PcG  com-
plexes  to  promote  transcriptional 
silencing.  Determining  the  fate  of 
these  siRNAs  and  what  proteins 
may  recognize  them  should  eluci-
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The nuclear protein kinase ATR is a key regulator of genome integrity that functions at check-
points for damaged or incompletely replicated DNA. In this issue of Cell, Kumagai et al. (2006) 
shed light on the molecular mechanism that controls ATR. They report that a physical interac-




such  as  cancer  (Kastan  and Bartek, 
2004). All eukaryotes share a network 





aged  cells  by  apoptosis.  Central  to 




sia and Rad3-related; Bakkenist and evier Inc.Kastan,  2004).  Despite  some  cross-
talk  between  these  two  upstream 
kinase modules, their  labor is largely 
divided,  in  that  ATM  responds  pri-
marily  to DNA double-strand breaks 
(DSBs), whereas ATR is crucial in the 
response  to  DNA  replication  stress 
and  a  broader  spectrum  of  DNA 
lesions.  Given  their  pivotal  roles  in 
the biological responses to genotoxic 
stress,  understanding  the  molecu-
lar  mechanisms  that  activate  ATM 
and ATR would facilitate advances in 
both basic and translational biomedi-
cal  research.  Whereas  recent  work 
has  elucidated  the  molecular  basis 
of  ATM  activation,  the  regulation  of 
ATR activity has been enigmatic. ATM 
forms inactive dimers in the absence 
of  DNA  damage.  When  sensing  a 
DSB,  ATM  undergoes  a  dimer-to-
monomer  transition  concomitant 
with  its  autophosphorylation  at  ser-
ine  residue  1981  and  an  increase  in 
kinase  activity.  Recruitment  of  ATM 
to the sties of damage is facilitated by 
a  cofactor  complex:  Mre11/Rad50/
Nbs1  (Bakkenist  and  Kastan,  2004; 
Falck  et  al.,  2005).  In  contrast,  ATR 
exists  as  a  heterodimeric  complex 
with ATR-interacting protein  (ATRIP), 
and  following genotoxic  insults ATR-
ATRIP  does  not  apparently  undergo 
any  detectable  change  in  oligomer-
ization  or  phosphorylation  status 
(Bakkenist  and  Kastan,  2004;  Falck 
et al., 2005; Zou and Elledge, 2003). 
Importantly,  it  has  been  difficult  or 
impossible  to detect any  increase  in 
ATR kinase activity under stress con-
ditions even when cellular responses 
rely  on  ATR. Consequently,  the  pre-
vailing  models  propose  that  ATR 
kinase  has  the  constitutive  capacity 




(Bakkenist  and  Kastan,  2004).  New 
exciting work by William Dunphy and 
colleagues,  reported  in  this  issue  of 
Cell (Kumagai et al., 2006), now chal-
lenges the “relocalization” model and 








(topoisomerase  IIβ  binding  protein 
1).  In  this model, TopBP1  is a direct 

















lator of ATR-ATRIP by strongly stimulating ATR kinase activity upon a direct association.C-terminal  (BRCT)  domains,  a  motif 
shared  by  numerous  proteins  impli-
cated  in  the  response  to DNA dam-
age  (Garcia  et  al.,  2005).  Kumagai 
et  al.  (2006)  identified  a  conserved 






The  isolated  ATR-activating  domain, 
but  not  other  segments  of  TopBP1, 
induced  ectopic  activation  of  ATR-
mediated  signaling  in  both  frog  egg 
extracts  and  human  cells.  Finally,  a 
subtle mutation within  the  ATR-acti-
vating  domain  rendered  TopBP1 
incapable of supporting ATR activity, 
and cells expressing mutant TopBP1 
failed  to mount  a proper  checkpoint Cell 124, response  when  exposed  to  DNA 
replication  inhibition.  Therefore,  this 
segment  of  TopBP1  appears  to  be 
both necessary and sufficient for ATR 







is  consistent  with  recent  reports 
that  also  appear  to  challenge  the 
“activation  by  relocalization”  con-
cept  that  relied  on  recruitment  of 
the  dispersed,  constitutively  active 
ATR-ATRIP  complexes  to  stretches 
of  single-stranded  DNA  that  are 
decorated  by  replication  protein  A 
(RPA;  Bakkenist  and  Kastan,  2004; 
Zou and Elledge, 2003). Thus, ATR-March 10, 2006 ©2006 Elsevier Inc.  889
ATRIP  does  not  need  to  associ-
ate  stably with  RPA-coated DNA  to 
activate Chk1 (Ball et al., 2005; Kim 
et  al.,  2005),  and  depletion  of  RPA 





that  establish  a  role  of  TopBP1  in 




ceptual  and mechanistic  issues  that 
deserve to be further considered and 
elucidated.  First,  future work  should 
establish what  stimulus and  through 
which molecular change(s) in TopBP1 
drives  the  formation  of  a  complex 
between  it  and  the preexisting ATR-




models,  to  detect  any  measurable 
increase in the kinase activity of ATR 
in  immunoprecipitates  from stressed 
cells.  The  authors  offer  a  plausible 
explanation and suggest that, through 
its binding, TopBP1 induces a confor-
mational  change  in  the  ATR-ATRIP 
complex  that  elevates  its  kinase 
activity.  Available  biochemical  evi-
dence  indicates  that  the  interaction 
of  TopBP1  with  ATR-ATRIP  is  likely 
only  transient  and  is  very  dynamic 
(Kumagai  et  al.,  2006).  By  analogy, 
very dynamic interactions also occur 




chemistry  or  cell  biology,  and  tech-
nical  tricks  to  slow  down  or  freeze 
such  rapid  spatiotemporal  changes 
are required in order to detect them. 
However,  the  dynamic  nature  of  the 
interaction  between  TopBP1  and 
ATR-ATRIP may not only explain  the 
largely  unsuccessful  attempts  to 
extract  an  active  form  of  mamma-
lian  ATR.  More  importantly,  such  a 
delicate  equilibrium  could  reflect  a 
critical  feature  of  this  versatile  regu-
latory mechanism that allows  for  the 
dynamic  control  of  ATR  function  at 
structures  such  as  replication  forks, 890  Cell 124, March 10, 2006 ©2006 Elswhich themselves appear and disap-
pear  rapidly  throughout  the  genome 
during S phase.
The  new  role  of  TopBP1  in  ATR 
activation arguably places this protein 
into the growing class of DNA-damage 
response  proteins  that  function  as 
adaptors  or  mediators  (Bakkenist 
and Kastan, 2004; Garcia et al., 2005; 
Kastan and Bartek 2004). This group 
of  checkpoint  regulators  includes 
53BP1,  BRCA1  and  MDC1  proteins, 
which  are  implicated  in  ATM-medi-
ated signaling, and Claspin, a protein 
that  facilitates  activation  of  Chk1  by 
ATR  (Chini and Chen, 2004). Among 




a wide  spectrum of  ATR  substrates, 







of  DNA  replication,  recombination, 







can  be  structurally  separated  from 
the ATR-activating function (Garcia et 
al., 2005; Kumagai et al., 2006). Accu-




tures  of  their  biochemistry  and  biol-
ogy  remain  to  be  elucidated  before 
their  complex  roles  in  orchestrating 
different aspects of DNA metabolism 
can be fully appreciated.
Finally,  the  discovery  of  TopBP1 
as  a  new  control  element within  the 
ATR-activation machinery could also 
inspire new avenues of research into 
the  pathologies  associated with  this 
regulatory  system.  Although  ATR  is 
an  essential  gene  whose  complete 
absence  results  in  early  embryonic 
lethality,  haploinsufficiency  of  ATR 
enhances tumorigenesis in mice, and evier Inc.hypomorphic  mutations  of  ATR  that 
result  in  low  levels  of  ATR  expres-
sion cause a complex human disease 
known  as  Seckel  syndrome  (Kastan 
and  Bartek,  2004).  However,  not  all 
cases  of  Seckel  syndrome  can  be 
attributed  to ATR mutations,  so  it  is 
possible  that  other  genetic  defects 
within  the  ATR  signaling  cascade, 
including TopBP1, might account  for 











to  the  alarms  raised  by  such  onco-
genic stress, and defects in TopBP1, 
along  those  that  target  the  ATM-
Chk2-p53  pathway,  for  example, 
may  provide  a  selective  advantage 
for nascent  tumors as  they progress 
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